Chemical compound
Pharmaceutical compound
Furafylline is a methylxanthine derivative that was introduced in hope of being a long-acting replacement for theophylline in the treatment of asthma.[1] It is an inhibitor of CYP1A2.[1]
References
- ^ a b Sesardic D, Boobis AR, Murray BP, Murray S, Segura J, de la Torre R, Davies DS (June 1990). "Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man". British Journal of Clinical Pharmacology. 29 (6): 651–63. doi:10.1111/j.1365-2125.1990.tb03686.x. PMC 1380167. PMID 2378786.
| PDE1 | |
|---|---|
| PDE2 | |
| PDE3 | |
| PDE4 |
|
| PDE5 | |
| PDE7 | |
| PDE9 | |
| PDE10 | |
| PDE11 | |
| Non-selective | |
| Unsorted | |
See also: Receptor/signaling modulators | |